| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.76(B) |
| Last
Volume: |
1,423,724 |
Avg
Vol: |
1,912,482 |
| 52
Week Range: |
$65.11 - $87.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
26,945 |
123,113 |
125,503 |
386,163 |
| Total Sell Value |
$2,043,551 |
$8,902,469 |
$9,102,584 |
$28,910,482 |
| Total People Sold |
3 |
6 |
6 |
11 |
| Total Sell Transactions |
3 |
8 |
9 |
19 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Griffin John M. |
General Counsel |
• • – |
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,052 |
183,296 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,176 |
14,951 |
|
- |
|
| Hellmann Elisabeth A |
SVP, Human Resources |
• • – |
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,353 |
10,916 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
103,447 |
2,459,666 |
|
- |
|
| Thornal Kevin R |
Div. President, Diagnostics |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,277 |
72,352 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2022-11-01 |
4 |
AS |
$72.50 |
$1,054,513 |
D/D |
(14,545) |
126,811 |
|
6% |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2022-11-01 |
4 |
OE |
$37.64 |
$564,076 |
D/D |
14,545 |
141,356 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,872 |
126,811 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,642 |
177,244 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,436 |
74,268 |
|
- |
|
| Mitchell Essex D |
Div. President, GYN SurgicalOf |
• – – |
2022-10-14 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
12,048 |
|
- |
|
| Anderson Erik S |
Div. Pres., Breast & SkeletalO |
• – – |
2022-10-14 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
10,999 |
|
- |
|
| Mitchell Essex D |
Div. President, GYN SurgicalOf |
• – – |
2022-10-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,196 |
|
27% |
|
| Anderson Erik S |
Div. Pres., Breast & SkeletalO |
• – – |
2022-10-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,587 |
|
27% |
|
| Verstreken Jan |
Group President, International |
• • – |
2022-07-01 |
4 |
D |
$70.14 |
$25,180 |
D/D |
(359) |
63,832 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2022-05-17 |
4 |
S |
$78.75 |
$302,730 |
D/D |
(3,844) |
13,532 |
|
19% |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2022-05-17 |
4 |
OE |
$40.85 |
$157,027 |
D/D |
3,844 |
17,376 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2022-05-17 |
4 |
S |
$78.80 |
$512,168 |
D/D |
(6,500) |
64,191 |
|
19% |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2022-05-13 |
4 |
S |
$75.49 |
$532,365 |
D/D |
(7,052) |
13,532 |
|
17% |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2022-05-13 |
4 |
OE |
$37.64 |
$277,770 |
D/D |
7,052 |
17,374 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
42,435 |
|
- |
|
| Wendell Amy Mcbride |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
17,693 |
|
- |
|
| Hantson Ludwig |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
8,055 |
|
- |
|
| Garrett Scott T |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
65,574 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,565 |
129,890 |
|
- |
|
1696 Records found
|
|
Page 6 of 68 |
|
|
0.51 (0.67%) 
